Is Saylor’s ‘sell kidney’ call a BTC exit?

The position was acquired for $61.81 billion at an average cost of $75,500 per coin. A net loss of $12.5 billion in the first quarter of 2026, driven by a decline in Bitcoin prices at the start of the year, provided the financial stress that led to the pivot. MSTR shares jumped 3% in after-hours trading following the announcement.

Will the strategy get rid of its entire collection? That almost certainly won’t happen. But thinking about selling when people are being asked to sell their kidneys is not a good thing.

Discover: Bitcoin Price Analysis – Key Support Levels and What Breaks Them

What happens to Bitcoin if the strategy starts selling?

Strategy’s 818,334 BTC is worth $61.8 billion at the average acquisition cost, but at the current spot value of $81,500, the position is worth $66.8 billion. The number is so large that a single order book cannot accommodate it cleanly.

The strategy’s purchases of $500 million to $1 billion worth of Bitcoin reliably lifted spot prices by 2% to 4% in the sessions following the reveal. The reverse dynamic of the coordinated selling program will face less liquidity on the demand side, especially below the $75,000 to $78,000 support band, where institutional bidding is concentrated.

Any meaningful disposal will almost certainly be routed through the OTC desks and not the exchange of order books. This limits slippage but does not eliminate the price effect. A mass sell-off of between 5,000 and 10,000 BTC would represent one of the largest single institutional transactions in the history of the last session and would carry significant signal weight regardless of where it is executed.

Le’s stated requirement to sell only when accumulating Bitcoin per share creates portfolios on the software. But the market liquidity, which ranges between $70,000 and $74,000, is weak. If Bitcoin falls below a company’s average cost basis, the calculus around servicing debt versus holding it changes fundamentally.

Forget the news, you can buy Bitcoin Hyper and still keep your kidneys

The current news for the strategy is scary for retail Bitcoin holders. People look for an asymmetric uptrend when Bitcoin is stuck below $100k, something that has the security of Bitcoin, is designed to fix Bitcoin’s flaws, and does not require selling a kidney to buy.

Bitcoin Hyper ($HYPER) It is an attention-grabbing project. Billed as the first-ever Bitcoin Layer 2 with Solana Virtual Machine (SVM) integration, it aims to address Bitcoin’s three fundamental limitations simultaneously: slow transactions, high fees, and limited programmability.

In short, Hyper provides final service in less than a second and executes low-cost smart contracts while inheriting Bitcoin’s security model.

The pre-sale has sparked more than $32.5 million At a current nominal price of $0.0136with 36% annually Staking is available to early participants. It’s still cheap, and at this high level, meaningful institutional and retail appetite is already there, but the price is still at an early stage by all accounts. Maintain your kidneys and get hyper.

Search for Bitcoin Hyper before the preview ends.